Shanghai UniXell Biotechnology
PrivateLast Round
Series A
Apr 18, 2025
Total Funding Raised
$71.38M
Company Overview
Shanghai UniXell Biotechnology is a biotechnology company that develops human pluripotent stem cell (hPSC) based cell therapies for neurodegenerative and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai UniXell Biotechnology Comparables
Compare Shanghai UniXell Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oryon Cell Therapies | 88% | |
| XellSmart | 87% | |
| iRegene Therapeutics | 86% |
Shanghai UniXell Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 18, 2025 | ||||
| Series A | Jul 12, 2024 | ||||
| Series A | Apr 4, 2024 | ||||
| Pre Seed | Mar 14, 2022 | ||||
| Angel | Aug 25, 2021 |
Shanghai UniXell Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hillhouse Investment | Pre Seed |
| Guokejiahe Fund | Series A |
| TF Capital | Pre Seed |
| CAS Venture Capital | Series A |
| Jiangsu Ruihua Investment Holding Group | Pre Seed |
| Kunlun Capital | Series A |
| Tasly Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2025
$19.18M round with participation from Guokejiahe Fund and Kunlun Capital.
- Jul 12, 2024
$1.38M round led by The Chinese Academy of Sciences Venture Capital Management
Recent news
Latest coverage and updates
- is_developingJun 25, 2026
Unixell is developing UX-DA003.
Shanghai UniXell Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shanghai UniXell Biotechnology's valuation, stock price, and market status.
Is Shanghai UniXell Biotechnology a public or private company?
Shanghai UniXell Biotechnology is a private company.
What is the current stock price of Shanghai UniXell Biotechnology?
Shanghai UniXell Biotechnology is a private company with no public stock price. No recent secondary market data is available.
How much is Shanghai UniXell Biotechnology worth (valuation)?
Valuation information for Shanghai UniXell Biotechnology is not publicly available.
Can I buy Shanghai UniXell Biotechnology stock?
Shanghai UniXell Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shanghai UniXell Biotechnology's last funding round?
Shanghai UniXell Biotechnology's most recent funding round was Series A on April 18, 2025.
Who are the main investors in Shanghai UniXell Biotechnology?
Key investors in Shanghai UniXell Biotechnology include Tasly Capital, Sherpa Healthcare Partners, CDH Investments.
Will Shanghai UniXell Biotechnology IPO soon?
No public IPO plans have been announced for Shanghai UniXell Biotechnology.
How can I track Shanghai UniXell Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shanghai UniXell Biotechnology's secondary market activity and sign up for updates.